炎症性腸疾患とUCとCDのサブグループのための可能なバイオマーカーとしての糞便の短鎖および分岐鎖酸? ケース・コントロール 研究
Justin K Gray1, Baochuan Guo1, Abdelraheem Baniahmad2
1Department of Chemistry, Cleveland State University, Cleveland, OH.
Journal of clinical gastroenterology
|August 21, 2025
まとめ
糞便の短鎖脂肪酸 (SCFA) と分岐鎖脂肪酸 (BCFA) は,炎症性腸疾患 (IBD) のバイオマーカーとして有望である. これらの代謝産物は,現在の糞便カルプロテクチン検査と比較して感度と特異性を改善します.
科学分野:
- 胃腸内科
- 臨床化学
- 微生物群の研究
背景:
- 炎症性腸疾患 (IBD) の病原性との関連が確立されているため,糞便の短鎖脂肪酸 (SCFA) と分岐鎖脂肪酸 (BCFA) に関する関心が高まっている.
- IBDは複雑な病理生理学で 腸内微生物の代謝物が重要な役割を果たします
研究 の 目的:
- IBDの診断バイオマーカーとして糞便のSCFAとBCFAの使用の可能性を調査する.
- これらの脂肪酸が,健康な個人とIBD患者,および潰瘍性大腸炎 (UC) とクローン病 (CD) のサブタイプを区別する可能性を評価する.
主な方法:
- 健康な個人,UC患者,CD患者の74個の便サンプルを対象としたケース・コントロール研究.
- ガス染色体質量測定法 (GC-MS) を使用した特定のSCFAおよびBCFAの定量化.
- 診断の正確性を決定するために,受信機操作者曲線 (ROC) 解析を用いたデータの分析.
主要な成果:
- 健康なグループとIBDグループを区別するために,高診断精度 (AUC 0. 96) を達成したSCFAの特異的変異は92%の感度と81%の特異性であった.
- 別の変異は,UCとCDのサブグループを区別するのに良い性能 (AUC 0. 83) を示し,75%の感度と86%の特異性を示した.
- 酸は最も豊富に存在するSCFAですが,その濃度は健康なグループとIBDグループ,またはUCとCDサブグループ間で有意に異なっていません.
結論:
- 糞便のSCFAとBCFAはIBDの実現可能なバイオマーカーであり,診断能力の改善の可能性を示しています.
- 提案されたSCFA/BCFAバイオマーカーの変容は,IBD検出のための糞便カルプロテクチン (FCP) テストよりも高い感度と特異性を示しています.
- 検証コホートに適した文献データが見つからなかったため,さらなる検証研究は必要である.
関連する概念動画
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
419
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
419
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
321
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
321
01:17Chronic Bowel Disorders: Introduction
540
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
540
01:30Inflammatory Bowel Disease II: Crohn's Disease
382
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
382
01:30Serum Laboratory Studies, Stool Test, Breath Test
474
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
474
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
245
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
245